OR WAIT null SECS
February 01, 2020
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.
January 27, 2020
Drug development contract services company PPD announces initial public offering.
December 17, 2019
The acquisition expands Charles River’s scientific capabilities in cell therapy development.
December 06, 2019
Cambrex reports that the acquisition by the investment group will facilitate ongoing growth.
November 25, 2019
The companies announced a commercial supply agreement following FDA’s accelerated approval.
November 22, 2019
New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.
Lubrizol Life Science Health adopts new name and opens commercial manufacturing facility.
October 15, 2019
Lonza, through its Ibex Solutions, will now cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline.
October 02, 2019
Limited guidance and numerous challenges create confusion about the scope and timing of stability testing for drugs in development.
October 01, 2019
An understanding-during early development-of the solid form landscape of an API can enhance product quality and manufacturing processes.